Bruker (BRKR) Cash from Financing Activities (2010 - 2026)

Bruker (BRKR) has 17 years of Cash from Financing Activities data on file, last reported at -$204.9 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 300.2% year-over-year to -$204.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.6 million (down 101.81% YoY) and the FY2025 annual result came in at $135.1 million, down 89.01% from the prior year.
• Cash from Financing Activities slipped to -$204.9 million in Q1 2026, from -$167.6 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $1.2 billion in Q2 2024 to a low of -$217.4 million in Q1 2022.
• A 5-year average of $32.4 million and a median of -$51.2 million in 2025 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 3053.85% — and 2024, when it jumped 11321.36%.
• Tracing BRKR's Cash from Financing Activities over 5 years: stood at -$36.1 million in 2022, then tumbled by 65.93% to -$59.9 million in 2023, then decreased by 25.21% to -$75.0 million in 2024, then tumbled by 123.47% to -$167.6 million in 2025, then slipped by 22.26% to -$204.9 million in 2026.
• The last three Cash from Financing Activities figures came in at -$204.9 million (Q1 2026), -$167.6 million (Q4 2025), and $258.4 million (Q3 2025), per Business Quant data.